The study used a statistical technique to evaluate outcomes for 2,550 patients who had switched from first generation basal insulin to Toujeo, matched with 2,550 who had switched to another old ...

Toujeo, which provides a steady insulin release over 24 hours via a once-daily injection, has become an essential solution for individuals with type 1 and type 2 diabetes. Its efficacy in ...